H Hampel Selected Research

H Hampel Research Topics

Disease

48	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 04/2000
21	Dementia (Dementias) 01/2015 - 06/2000
18	Cognitive Dysfunction 01/2019 - 04/2000
5	Atrophy 01/2019 - 07/2003
3	Brain Diseases (Brain Disorder) 12/2014 - 08/2000
3	Amyloid Plaque 02/2012 - 09/2001
3	Disease Progression 11/2008 - 05/2002
3	Mental Disorders (Mental Disorder) 01/2001 - 04/2000
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2017 - 12/2016
2	Inflammation (Inflammations) 02/2015 - 05/2000
2	Neoplasms (Cancer) 12/2001 - 10/2000
1	Frontotemporal Dementia (Semantic Dementia) 01/2016
1	Pathologic Processes 12/2014
1	Amyloidosis 01/2014
1	Schizophrenia (Dementia Praecox) 07/2012
1	Memory Disorders (Memory Loss) 02/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2011
1	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2011
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2011
1	Uterine Neoplasms (Uterine Cancer) 01/2008
1	Psychotic Disorders (Schizoaffective Disorder) 05/2005
1	Stroke (Strokes) 05/2005
1	Lewy Body Disease (Lewy Body Dementia) 05/2003
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2003
1	Microsatellite Instability 12/2002
1	Colorectal Neoplasms (Colorectal Cancer) 12/2002
1	Gliosis 09/2001
1	Ascites 07/2001
1	Bacteremia 07/2001
1	Urinary Tract Infections (Urinary Tract Infection) 07/2001
1	Fibrosis (Cirrhosis) 07/2001
1	Hemorrhage 07/2001
1	Liver Diseases (Liver Disease) 07/2001
1	Acute Kidney Injury (Acute Renal Failure) 07/2001
1	Peritonitis 07/2001
1	Demyelinating Diseases (Demyelinating Disease) 06/2001
1	Multiple Sclerosis 06/2001

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2001
8	Amyloid beta-PeptidesIBA 06/2010 - 05/2000
7	Amyloid (Amyloid Fibrils)IBA 02/2015 - 09/2001
7	Proteins (Proteins, Gene)FDA Link 12/2014 - 04/2000
6	tau Proteins (tau Protein)IBA 01/2016 - 04/2001
5	Apolipoproteins E (ApoE)IBA 01/2016 - 04/2000
4	Biological ProductsIBA 10/2013 - 03/2004
4	Glucose (Dextrose)FDA LinkGeneric 11/2008 - 07/2003
4	AntibodiesIBA 01/2008 - 06/2001
3	ApolipoproteinsIBA 12/2013 - 04/2000
3	Threonine (L-Threonine)FDA Link 08/2002 - 06/2000
2	Indicators and Reagents (Reagents)IBA 12/2014 - 04/2000
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Galantamine (Galanthamine)FDA LinkGeneric 06/2012
1	SynucleinsIBA 12/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2011
1	Carrier Proteins (Binding Protein)IBA 12/2011
1	UbiquitinIBA 12/2011
1	Peptides (Polypeptides)IBA 06/2010
1	Pemetrexed (MTA)FDA Link 10/2009
1	Protein Isoforms (Isoforms)IBA 03/2009
1	Memantine (Namenda)FDA Link 02/2005
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2004
1	amyloid beta-protein (1-42)IBA 03/2004
1	progressinIBA 07/2003
1	Nootropic Agents (Nootropics)IBA 05/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2001
1	Fatty Acid-Binding ProteinsIBA 12/2001
1	Apolipoprotein E4IBA 08/2001
1	Serine (L-Serine)FDA Link 08/2001
1	Amino Acids FDA Link 08/2001
1	BilirubinIBA 07/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2001
1	CreatinineIBA 07/2001
1	AminoglycosidesIBA 07/2001
1	AlbuminsIBA 07/2001
1	AutoantibodiesIBA 06/2001
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2001
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2001
1	RNA Splice SitesIBA 11/2000
1	LipidsIBA 10/2000
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2000
1	Dual-Specificity PhosphatasesIBA 10/2000
1	Antipsychotic Agents (Antipsychotics)IBA 08/2000
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 04/2000

Therapy/Procedure

12	Therapeutics 01/2019 - 06/2000
3	Precision Medicine 01/2018 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 02/2005
2	Secondary Prevention 01/2015 - 05/2005
1	Cognitive Training 01/2015